Another study supported these findings, showing that S100A9 expression is elevated in MDS patients and promotes the senescence phenotype of bone marrow stromal cells via Toll like receptor 4 (TLR4) signaling, NLRP3 inflammasome formation and IL-1β secretion [76]. Here, S100A9 is linked to myelodysplastic syndrome.